Treatment Effectiveness
User reported effectiveness ratings Imipramine for various conditions.
Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
---|---|---|---|---|---|---|
Back Pain | 8% | 15% | 15% | 54% | 8% | 13 |
Depression | 6% | 22% | 16% | 46% | 10% | 50 |
Mitral Valve Prolapse | 20% | 20% | 20% | 30% | 10% | 10 |
Vulvodynia | 11% | 26% | 0% | 53% | 11% | 19 |
Anxiety | 5% | 23% | 16% | 33% | 23% | 43 |
Side Effects
User-reported side effects of Imipramine
Side Effect | Percent of Reports Imipramine |
---|---|
Constipation | 36% |
Dry Mouth | 64% |
Blurred Vision | 20% |
Changes in Appetite or Weight | 25% |
Changes in Sex Drive or Ability | 18% |
Difficulty Urinating | 12% |
Drowsiness | 47% |
Excessive Sweating | 33% |
Excitement or Anxiety | 27% |
Frequent Urination | 10% |
Nightmares | 12% |
Skin More Sensitive to Sunlight Than Usual | 18% |
Weakness or Tiredness | 45% |
Nausea | 20% |
Outcomes
Below is the degree of change seen after Imipramine is higher than average.

Outcomes Label
Outcomes
of
Below is the change in the listed outcome after
is higher than average.
(Math.abs(a['change']) < Math.abs(b['change'])) ? 1 : -1)"
title="Click to put the results with the largest observed change at the top"
>
Sort by Effect Size
(a['number_of_days'] < b['number_of_days']) ? 1 : -1)"
title="Click to put the results with the most supporting data points at the top."
>
Sort by Confidence
Imipramine Info
Property | Value |
---|---|
Variable Name | Imipramine |
Aggregation Method | SUM |
Analysis Performed At | 2020-05-06 |
Duration of Action | 21 days |
Filling Value | 0 |
Minimum Allowed Value | 0 count |
Number of Aggregate Predictors | 0 |
Number of Aggregate Outcomes | 0 |
Number of Measurements | 0 |
Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
Public | true |
Onset Delay | 30 minutes |
Unit | Count |
User Variables | 0 |
Variable Category | Treatments |
Variable ID | 93940 |